Skip to main content

Michael R Abern, MD

Associate Professor of Surgery
Office: 40 Duke Medicine Circle, DUMC Box 3707, Durham, NC 27710
Campus Mail: DUMC 200 Trent Drive, DUMC Box 2804, Durham, NC 27710

Education and Training

  • Urologic Oncology Fellow, Surgery, Duke University School of Medicine, 2011 - 2013
  • Urology Resident, Surgery, Rush University Medical Center, 2006 - 2011
  • M.D., Rush University, Medical College, 2006
  • B.S., University of Illinois, 1996

Publications

Tan, Wei Phin, Dimitri Papagiannopoulos, Kalyan C. Latchamsetty, Nathaniel Wilson, Nicholas O’Block, Lester Raff, Alfredo Mena Lora, Christopher L. Coogan, and Michael R. Abern. “Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.” Prostate Cancer Prostatic Dis 22, no. 2 (May 2019): 268–75. https://doi.org/10.1038/s41391-018-0092-3.

Full Text

Vijayakumar, Vish, Jyotsna S. Jagai, Michael R. Abern, and Andre Kajdacsy-Balla. “Association between cadmium Air Exposure and Prostrate Cancer Stage at Diagnosis.” In Faseb Journal, Vol. 33, 2019.

Scholars@Duke

Schwarzman, Logan, Rodrigo Pagani, Samuel Ohlander, Michael Abern, Gerald Andriole, Stephen Freedland, and Daniel Moreira. “DIAGNOSTIC PROPERTIES OF PROSTATE-SPECIFIC ANTIGEN TO PREDICT PROSTATE CANCER AND CLINICALLY SIGNIFICANT PROSTATE CANCER AMONG MEN WITH ANDROGEN DEFICIENCY.” In Journal of Urology, 201:E652–E652, 2019.

Scholars@Duke

Vigneswaran, Hari T., Meltem Uyanik, Rolf Reiter, Virgilia Macias, Winnie Mar, Karen L. Xie, Richard L. Magin, and Michael R. Abern. “IMPROVED ACCURACY OF MRI/US FUSION PROSTATE BIOPSY USING A STRETCHED EXPONENTIAL DIFFUSION PARAMETER.” In Journal of Urology, 201:E1079–E1079, 2019.

Scholars@Duke

Madueke, Ikenna, Wen-Yang Hu, Danping Hu, Michael Abern, and Gail Prins. “SIGNIFICANCE OF CANONICAL WNT10B IN PROSTATE GLAND DEVELOPMENT AND CARCINOGENESIS.” In Journal of Urology, 201:E977–78, 2019.

Scholars@Duke

Zenner, Morgan, Michael Abern, Ruben Sauer, Gayatry Mohapatra, Klara Valyi-Nagy, and Larisa Nonn. “THE POTENTIAL FOR CIRCULATING EXTRACELLULAR VESICLE MICRORNAS TO PREDICT PROSTATE CANCER AGGRESSIVENESS.” In Journal of Urology, 201:E341–42, 2019.

Scholars@Duke

Dobbs, Ryan W., Neha R. Malhotra, Michael R. Abern, and Daniel M. Moreira. “Prostate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis.” Prostate Cancer Prostatic Dis 22, no. 1 (March 2019): 159–67. https://doi.org/10.1038/s41391-018-0097-y.

Full Text

Caldwell, Brandon, David Greenwald, Daniel Moreira, Rong-Wen Tain, Christopher Coogan, Karen Xie, Winnie Mar, Peter Pfanner, and Michael Abern. “Constructing and Pilot Testing a Novel Prostate Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Phantom.” Urology 124 (February 2019): 33–37. https://doi.org/10.1016/j.urology.2018.10.029.

Full Text

Schwarzman, Logan S., Michael R. Abern, Daniel F. Garvey, Gerald L. Andriole, Stephen J. Freedland, and Daniel M. Moreira. “The Association of Previous Prostate Biopsy Related Complications and the Type of Complication with Patient Compliance with Rebiopsy Scheme.” J Urol 200, no. 5 (November 2018): 1062–67. https://doi.org/10.1016/j.juro.2018.06.018.

Full Text

Tsivian, Matvey, Michael R. Abern, Efrat Tsivian, Christina Sze, Ghalib Jibara, Edward N. Rampersaud, and Thomas J. Polascik. “Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma.” Urol Oncol 36, no. 8 (August 2018): 362.e1-362.e7. https://doi.org/10.1016/j.urolonc.2018.04.014.

Full Text

Pages